Deciphera Pharmaceuticals IncNASDAQ:DCPH
- LAST PRICE11.7300
- TODAY'S CHANGE (%)-0.1100 (-0.9291%)
- Bid / Lots10.0500/ 1
- Ask / Lots11.8000/ 1
- Open / Previous Close11.9500 / 11.8400
- Day Range
- 52 Week Range
- Volume1,029,970
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DCPH |
|---|---|---|
| 09:32 ET | 8835 | 11.86 |
| 09:34 ET | 1052 | 11.8 |
| 09:36 ET | 4584 | 11.76 |
| 09:38 ET | 2300 | 11.78 |
| 09:39 ET | 1800 | 11.66 |
| 09:41 ET | 430 | 11.7 |
| 09:43 ET | 500 | 11.6 |
| 09:45 ET | 3816 | 11.84 |
| 09:48 ET | 4368 | 11.9 |
| 09:50 ET | 2625 | 11.9 |
| 09:52 ET | 6729 | 11.9874 |
| 09:54 ET | 16871 | 12.06 |
| 09:56 ET | 3114 | 12.04 |
| 09:57 ET | 2670 | 11.94 |
| 09:59 ET | 2741 | 11.94 |
| 10:01 ET | 3648 | 11.836 |
| 10:03 ET | 2538 | 11.75 |
| 10:06 ET | 1788 | 11.775 |
| 10:08 ET | 1200 | 11.73 |
| 10:10 ET | 1110 | 11.73 |
| 10:12 ET | 200 | 11.73 |
| 10:14 ET | 640 | 11.77 |
| 10:15 ET | 200 | 11.84 |
| 10:17 ET | 200 | 11.87 |
| 10:19 ET | 950 | 11.87 |
| 10:21 ET | 3430 | 11.85 |
| 10:24 ET | 11730 | 11.8 |
| 10:26 ET | 600 | 11.7 |
| 10:28 ET | 2450 | 11.6218 |
| 10:30 ET | 20293 | 11.65 |
| 10:32 ET | 1929 | 11.66 |
| 10:33 ET | 3081 | 11.7735 |
| 10:35 ET | 4534 | 11.77 |
| 10:37 ET | 1852 | 11.71 |
| 10:39 ET | 300 | 11.7 |
| 10:42 ET | 3829 | 11.68 |
| 10:44 ET | 1300 | 11.67 |
| 10:46 ET | 900 | 11.7 |
| 10:48 ET | 1800 | 11.69 |
| 10:50 ET | 1100 | 11.72 |
| 10:51 ET | 1400 | 11.66 |
| 10:53 ET | 11818 | 11.69 |
| 10:55 ET | 1034 | 11.72 |
| 10:57 ET | 6035 | 11.72 |
| 11:00 ET | 3350 | 11.69 |
| 11:02 ET | 1342 | 11.71 |
| 11:04 ET | 2411 | 11.73 |
| 11:06 ET | 2139 | 11.78 |
| 11:08 ET | 31900 | 11.8 |
| 11:09 ET | 2294 | 11.74 |
| 11:11 ET | 500 | 11.675 |
| 11:13 ET | 1549 | 11.68 |
| 11:15 ET | 600 | 11.7 |
| 11:18 ET | 3219 | 11.72 |
| 11:20 ET | 1000 | 11.695 |
| 11:22 ET | 2204 | 11.68 |
| 11:24 ET | 1800 | 11.68 |
| 11:26 ET | 1974 | 11.69 |
| 11:27 ET | 2441 | 11.68 |
| 11:29 ET | 1698 | 11.7 |
| 11:31 ET | 3500 | 11.73 |
| 11:33 ET | 700 | 11.77 |
| 11:36 ET | 3323 | 11.841 |
| 11:38 ET | 3750 | 11.86 |
| 11:40 ET | 400 | 11.85 |
| 11:42 ET | 600 | 11.841 |
| 11:44 ET | 515 | 11.84 |
| 11:45 ET | 2314 | 11.86 |
| 11:47 ET | 1428 | 11.86 |
| 11:49 ET | 4063 | 11.86 |
| 11:51 ET | 5274 | 11.89 |
| 11:54 ET | 330 | 11.91 |
| 11:56 ET | 1064 | 11.87 |
| 11:58 ET | 1000 | 11.84 |
| 12:00 ET | 1443 | 11.81 |
| 12:02 ET | 800 | 11.81 |
| 12:03 ET | 450 | 11.81 |
| 12:05 ET | 2629 | 11.81 |
| 12:07 ET | 539 | 11.82 |
| 12:09 ET | 900 | 11.83 |
| 12:12 ET | 2040 | 11.765 |
| 12:14 ET | 1012 | 11.75 |
| 12:18 ET | 1300 | 11.73 |
| 12:20 ET | 300 | 11.74 |
| 12:21 ET | 2300 | 11.8 |
| 12:23 ET | 1194 | 11.8 |
| 12:25 ET | 300 | 11.82 |
| 12:27 ET | 1900 | 11.831 |
| 12:30 ET | 500 | 11.785 |
| 12:32 ET | 700 | 11.75 |
| 12:34 ET | 200 | 11.76 |
| 12:36 ET | 1222 | 11.77 |
| 12:38 ET | 554 | 11.791 |
| 12:39 ET | 800 | 11.79 |
| 12:41 ET | 7100 | 11.79 |
| 12:43 ET | 200 | 11.79 |
| 12:45 ET | 900 | 11.81 |
| 12:48 ET | 538 | 11.8 |
| 12:50 ET | 8693 | 11.86 |
| 12:52 ET | 1693 | 11.84 |
| 12:54 ET | 6750 | 11.83 |
| 12:56 ET | 600 | 11.83 |
| 12:57 ET | 600 | 11.82 |
| 12:59 ET | 400 | 11.83 |
| 01:01 ET | 834 | 11.82 |
| 01:03 ET | 627 | 11.84 |
| 01:06 ET | 7330 | 11.84 |
| 01:10 ET | 12794 | 11.83 |
| 01:12 ET | 1024 | 11.801 |
| 01:14 ET | 1590 | 11.82 |
| 01:15 ET | 1100 | 11.79 |
| 01:17 ET | 5470 | 11.81 |
| 01:19 ET | 400 | 11.81 |
| 01:21 ET | 1773 | 11.79 |
| 01:24 ET | 700 | 11.81 |
| 01:26 ET | 1703 | 11.85 |
| 01:28 ET | 13000 | 11.815 |
| 01:30 ET | 100 | 11.805 |
| 01:32 ET | 700 | 11.74 |
| 01:33 ET | 3300 | 11.78 |
| 01:35 ET | 100 | 11.81 |
| 01:37 ET | 600 | 11.82 |
| 01:39 ET | 1018 | 11.8425 |
| 01:42 ET | 1334 | 11.85 |
| 01:44 ET | 3471 | 11.86 |
| 01:46 ET | 800 | 11.87 |
| 01:48 ET | 1313 | 11.9215 |
| 01:50 ET | 1017 | 11.93 |
| 01:51 ET | 400 | 11.92 |
| 01:53 ET | 2100 | 11.92 |
| 01:55 ET | 300 | 11.92 |
| 01:57 ET | 2233 | 11.93 |
| 02:00 ET | 800 | 11.931 |
| 02:02 ET | 1661 | 11.87 |
| 02:04 ET | 2913 | 11.872 |
| 02:06 ET | 1900 | 11.85 |
| 02:08 ET | 700 | 11.85 |
| 02:09 ET | 500 | 11.87 |
| 02:11 ET | 2282 | 11.9 |
| 02:13 ET | 600 | 11.92 |
| 02:15 ET | 500 | 11.925 |
| 02:18 ET | 900 | 11.92 |
| 02:20 ET | 1000 | 11.92 |
| 02:22 ET | 1200 | 11.93 |
| 02:24 ET | 1500 | 11.91 |
| 02:26 ET | 800 | 11.92 |
| 02:29 ET | 6301 | 11.91 |
| 02:31 ET | 1808 | 11.87 |
| 02:33 ET | 800 | 11.875 |
| 02:36 ET | 1300 | 11.85 |
| 02:38 ET | 10728 | 11.83 |
| 02:40 ET | 1020 | 11.8 |
| 02:42 ET | 3623 | 11.81 |
| 02:44 ET | 1745 | 11.85 |
| 02:45 ET | 1080 | 11.88 |
| 02:47 ET | 1300 | 11.88 |
| 02:49 ET | 8610 | 11.86 |
| 02:51 ET | 100 | 11.88 |
| 02:54 ET | 1859 | 11.86 |
| 02:56 ET | 1836 | 11.89 |
| 02:58 ET | 1000 | 11.89 |
| 03:00 ET | 600 | 11.9 |
| 03:02 ET | 2797 | 11.91 |
| 03:03 ET | 1504 | 11.891 |
| 03:05 ET | 503 | 11.9 |
| 03:07 ET | 2226 | 11.89 |
| 03:09 ET | 3212 | 11.88 |
| 03:12 ET | 1880 | 11.84 |
| 03:14 ET | 1400 | 11.82 |
| 03:16 ET | 20707 | 11.77 |
| 03:18 ET | 2008 | 11.75 |
| 03:20 ET | 3400 | 11.76 |
| 03:21 ET | 3006 | 11.77 |
| 03:23 ET | 910 | 11.74 |
| 03:25 ET | 1900 | 11.735 |
| 03:27 ET | 4606 | 11.79 |
| 03:30 ET | 1087 | 11.79 |
| 03:32 ET | 2042 | 11.8 |
| 03:34 ET | 2645 | 11.8 |
| 03:36 ET | 1963 | 11.795 |
| 03:38 ET | 4836 | 11.77 |
| 03:39 ET | 2200 | 11.75 |
| 03:41 ET | 3300 | 11.74 |
| 03:43 ET | 3877 | 11.735 |
| 03:45 ET | 3614 | 11.735 |
| 03:48 ET | 3690 | 11.7 |
| 03:50 ET | 3477 | 11.715 |
| 03:52 ET | 9082 | 11.72 |
| 03:54 ET | 4413 | 11.735 |
| 03:56 ET | 12614 | 11.705 |
| 03:57 ET | 17631 | 11.725 |
| 03:59 ET | 108747 | 11.73 |
May 4, 2022
BRIEF-Deciphera Pharmaceuticals Says Qtrly Loss Per Share $0.80 , from 8:56AM ET on Wednesday May 04, 2022 by Thomson Reuters
8:56AM ET on Wednesday May 04, 2022 by Thomson ReutersBRIEF-Deciphera Pharmaceuticals Announces First Quarter 2022 Results, from 8:56AM ET on Wednesday May 04, 2022 by Thomson Reuters
8:56AM ET on Wednesday May 04, 2022 by Thomson Reuters-- Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Posts Q1 Revenue $29.2M, vs. Street Est of $27.2M, from 7:03AM ET on Wednesday May 04, 2022 by MT Newswires
7:03AM ET on Wednesday May 04, 2022 by MT Newswires-- Earnings Flash (DCPH) DECIPHERA PHARMACEUTICALS Posts Q1 Loss $-0.80, vs. Street Est of $-0.88, from 7:03AM ET on Wednesday May 04, 2022 by MT Newswires
7:03AM ET on Wednesday May 04, 2022 by MT NewswiresDeciphera Pharmaceuticals, Inc. Announces First Quarter 2022 Financial Results, from 7:00AM ET on Wednesday May 04, 2022 by Business Wire
7:00AM ET on Wednesday May 04, 2022 by Business Wire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Deciphera Pharmaceuticals Inc | 784.0M | -2.4x | --- |
Avid Bioservices Inc | 781.7M | 79.7x | --- |
Enanta Pharmaceuticals Inc | 867.2M | -7.7x | --- |
ImmunoGen Inc | 789.5M | -6.0x | --- |
Kymera Therapeutics Inc | 765.0M | -6.0x | --- |
Codexis Inc | 685.0M | -33.0x | --- |
Company Information
Deciphera Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and delivering medicines to patients for the treatment of cancer. The Company has developed a switch-control kinase inhibitor platform in kinase biology to execute its strategy to develop a broad portfolio of medicines. The Company has one approved drug, QINLOCK, which is a switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). In addition, the Company is developing three clinical-stage drug candidates, which includes Vimseltinib (DCC-3014) - colony stimulating factor 1 receptor (CSF1R) Kinase Inhibition for Tenosynovial Giant Cell Tumor (TGCT), Rebastinib - TEK tyrosine kinase (TIE2) Kinase Inhibition for advanced or Metastatic Solid Tumors, and DCC-3116 - ULK Kinase Inhibition for Mutant RAS/RAF Cancers.
Contact Information
- Headquarters
- 200 Smith StWALTHAM, MA, United States 02451-0099
- Phone
- 781-209-6400
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- James Bristol
- President, Chief Executive Officer, Director
- Steven Hoerter
- Founder, Executive Vice President, Chief Scientific Officer
- Daniel Flynn
- Chief Financial Officer, Executive Vice President, Treasurer
- Thomas Kelly
- Executive Vice President, Chief Medical Officer
- Matthew Sherman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $784.0M |
|---|---|
Revenue (TTM) | $100.2M |
Shares Outstanding | 66.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.29 |
EPS | $-4.90 |
Book Value | $5.20 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 7.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -284.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
